Log in

ETR:FMEFresenius Medical Care AG & Co. KGaA Stock Price, Forecast & News

€75.26
-0.36 (-0.48 %)
(As of 05/29/2020 08:13 AM ET)
Add
Compare
Today's Range
€74.36
Now: €75.26
€75.52
50-Day Range
€61.62
MA: €69.79
€76.70
52-Week Range
€53.50
Now: €75.26
€81.10
Volume299,344 shs
Average Volume704,197 shs
Market Capitalization$22.08 billion
P/E Ratio18.67
Dividend Yield1.62%
BetaN/A
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Read More
Fresenius Medical Care AG & Co. KGaA logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 3.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.69 out of 5 stars


Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-6172-6090

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.83 billion
Cash Flow€4.81 per share
Book Value€40.90 per share

Profitability

Miscellaneous

Employees112,658
Market Cap$22.08 billion
Next Earnings Date7/30/2020 (Estimated)
OptionableNot Optionable

Receive FME News and Ratings via Email

Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter.

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Frequently Asked Questions

How has Fresenius Medical Care AG & Co. KGaA's stock been impacted by COVID-19 (Coronavirus)?

Fresenius Medical Care AG & Co. KGaA's stock was trading at €63.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, FME shares have increased by 18.2% and is now trading at €75.26. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Fresenius Medical Care AG & Co. KGaA?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Fresenius Medical Care AG & Co. KGaA.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

Fresenius Medical Care AG & Co. KGaA is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Fresenius Medical Care AG & Co. KGaA.

What price target have analysts set for FME?

16 Wall Street analysts have issued 12-month price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their forecasts range from €69.50 to €100.00. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's stock price to reach €81.40 in the next year. This suggests a possible upside of 8.2% from the stock's current price. View analysts' price targets for Fresenius Medical Care AG & Co. KGaA.

Has Fresenius Medical Care AG & Co. KGaA been receiving favorable news coverage?

Media coverage about FME stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Fresenius Medical Care AG & Co. KGaA earned a media sentiment score of 0.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the stock's share price in the near term. View the latest news aboutFresenius Medical Care AG & Co. KGaA.

Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors?

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Petra Diamonds (PDL), Nokia Oyj (NOKIA), Fresenius Medical Care AG & Co. (FMS), Rio Tinto (RIO), RWE (RWE), Carillion (CLLN), Nokia Oyj (NOK), Oxford BioMedica (OXB), AT&T (T) and Oracle (ORCL).

Who are Fresenius Medical Care AG & Co. KGaA's key executives?

Fresenius Medical Care AG & Co. KGaA's management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FME stock can currently be purchased for approximately €75.26.

How big of a company is Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA has a market capitalization of $22.08 billion and generates $17.83 billion in revenue each year. Fresenius Medical Care AG & Co. KGaA employs 112,658 workers across the globe.

What is Fresenius Medical Care AG & Co. KGaA's official website?

The official website for Fresenius Medical Care AG & Co. KGaA is www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.